-+ 0.00%
-+ 0.00%
-+ 0.00%

JMP Securities Maintains Market Outperform on Bicycle Therapeutics, Lowers Price Target to $22

Benzinga·05/02/2025 14:18:45
Listen to the news
JMP Securities analyst Reni Benjamin maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Market Outperform and lowers the price target from $26 to $22.